Involvement of JAK/STAT signalling in the pathogenesis of inflammatory bowel disease - Publications - Cytokine Signalling Forum
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
Comparing Small Molecules and Biologics | Clinical Practice Snapshot: Incorporating Janus Kinase Inhibitors Into the Management of Rheumatoid Arthritis | Global Academy for Medical Education
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis - ScienceDirect
Oral surveillance and JAK inhibitor safety: the theory of relativity | Nature Reviews Rheumatology
JAK Inhibitors | JAK Inhibitors Market | Janus Kinase Inhibitors
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases
How Do JAK Inhibitors Treat Rheumatoid Arthritis? | myRAteam
Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect
![PDF] The Jak-STAT pathway in rheumatoid arthritis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9f3e08162ea010837b898db37a95d090d447e097/3-Figure1-1.png "PDF] The Jak-STAT pathway in rheumatoid arthritis. | Semantic Scholar")
PDF] The Jak-STAT pathway in rheumatoid arthritis. | Semantic Scholar
JAK Inhibitor 瑞石生物医药有限公司
![PDF] Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/845f77db3e8de4c43bbcb5a7c172cbcdcc27298a/3-Figure2-1.png "PDF] Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. | Semantic Scholar")
PDF] Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. | Semantic Scholar
Frequent switching between JAK inhibitors observed in patients with RA
Eli Lilly's Olumiant: how will it far among JAK inhibitors? - Pharmaceutical Technology
Jackie and Jill: Talking About JAK Inhibitors While Caring for RA Patients | Ontario Pharmacists Association
After 25 years of drug development, do we know JAK? | RMD Open
Pfizer's JAK inhibitor sails through phase 3 in rheumatoid arthritis | Nature Biotechnology
The JAK/STAT Pathway in Rheumatoid Arthritis - YouTube
Consumer's Guide to RA and JAK Inhibitors | Everyday Health
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
The Role of Janus Kinase in RA Pathogenesis | Clinical Practice Snapshot: Incorporating Janus Kinase Inhibitors Into the Management of Rheumatoid Arthritis | Global Academy for Medical Education
The Use of JAK Inhibitors in RA: Overall Efficacy | Clinical Practice Snapshot: Incorporating Janus Kinase Inhibitors Into the Management of Rheumatoid Arthritis | Global Academy for Medical Education
Second-Line Treatment of Rheumatoid Arthritis: What Are the Options? | MedPage Today
